Read e-book online Adenosine Receptors - Therapeutic Asps. for Inflamm., Immune PDF

By G. Hasko

ISBN-10: 0849339995

ISBN-13: 9780849339998

Show description

Read or Download Adenosine Receptors - Therapeutic Asps. for Inflamm., Immune Diseases PDF

Best diseases books

Download e-book for kindle: Prescribing Hemodialysis: A Guide to Urea Modeling by Thomas A. Depner M.D. (auth.)

What rules we could have for the operation? Shall a guy transfuse he is aware no longer what. to right he is aware now not what. God understands how (l)? Dr. Henry Stubbs Royal university of Physicians circa 1670 If dialysis treatment have been a brand new phannaceutical product being evaluated by way of the FDA now, it could now not be licensed for advertising.

Extra info for Adenosine Receptors - Therapeutic Asps. for Inflamm., Immune Diseases

Example text

7 PYRAZOLOQUINOLINES The 2-aryl-pyrazolo [4,3-c] quinolin-4-one skeleton was recently reported as a template for selective A3AR antagonists. 0 nM. fm Page 32 Wednesday, May 24, 2006 3:00 PM 32 Adenosine Receptors were also identified in a library of compounds described earlier as a source of A3AR antagonists. 9 THIAZOLES AND THIADIAZOLES Thiazole and thiadiazole analogs 75–79 were first identified as a promising class of compounds after the screening of several 5- and 6-membered heterocyclic core templates to replace isoquinoline and quinazoline skeletons for new adenosine receptor antagonists.

42, 4473, 1999. 46. G. , Synthesis and preliminary biological evaluation of [3H]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors, Bioorg. Med. Chem. , 10, 209, 2000. 47. G. , Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A3 adenosine receptor antagonists, J. Med. , 45, 770, 2002. 48. Maconi, A. , Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A3 adenosine receptor antagonist, J.

Selective agonists are in clinical trials for the treatment of rheumatoid arthritis and cancer. Selective antagonists are in preclinical testing for the treatment of glaucoma. In addition to the potential of directly acting orthosteric ligands, modulation of the ARs allosterically is a promising line of inquiry. The approach of genetic therapy with neoceptors could further achieve organ or tissue selectivity in the future. V. Joshi thanks Gilead Sciences, Foster City, CA, for financial support.

Download PDF sample

Adenosine Receptors - Therapeutic Asps. for Inflamm., Immune Diseases by G. Hasko

by Donald

Rated 4.93 of 5 – based on 6 votes

Author: admin